Keith D. Dawkins, EVP, Global Chief Med. Officer at BOSTON SCIENTIFIC CORP (BSX), sold 161,566 shares at $25.21 ($4.1M) on 2017-02-07, disclosed to the SEC on 2017-02-08.
Seasonal sale ($4.1M) by EVP, Global Chief Med. Officer — this insider has traded BSX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.21 | 80,783 | $2.0M | 50.0% |
| 2 | $25.21 | 80,783 | $2.0M | 50.0% |
| Total | $25.21 avg | 161,566 | $4.1M | 100% |
| Filing → |
| BSX | SELL | 2013-11-25 | $1.7M | — | Filing → |